These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31799993)

  • 1. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
    DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
    JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
    Hollon SD; DeRubeis RJ; Fawcett J; Amsterdam JD; Shelton RC; Zajecka J; Young PR; Gallop R
    JAMA Psychiatry; 2014 Oct; 71(10):1157-64. PubMed ID: 25142196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients.
    Bossarte RM; Kessler RC; Nierenberg AA; Chattopadhyay A; Cuijpers P; Enrique A; Foxworth PM; Gildea SM; Belnap BH; Haut MW; Law KB; Lewis WD; Liu H; Luedtke AR; Pigeon WR; Rhodes LA; Richards D; Rollman BL; Sampson NA; Stokes CM; Torous J; Webb TD; Zubizarreta JR
    Trials; 2022 Jun; 23(1):520. PubMed ID: 35725644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis.
    Zhang Z; Zhang L; Zhang G; Jin J; Zheng Z
    BMC Psychiatry; 2018 Feb; 18(1):50. PubMed ID: 29475431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
    Dunlop BW; LoParo D; Kinkead B; Mletzko-Crowe T; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    Am J Psychiatry; 2019 Apr; 176(4):275-286. PubMed ID: 30764648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial.
    Freedland KE; Carney RM; Rich MW; Steinmeyer BC; Rubin EH
    JAMA Intern Med; 2015 Nov; 175(11):1773-82. PubMed ID: 26414759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2014 Jun; 15():217. PubMed ID: 24916319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial.
    Irwin MR; Carrillo C; Sadeghi N; Bjurstrom MF; Breen EC; Olmstead R
    JAMA Psychiatry; 2022 Jan; 79(1):33-41. PubMed ID: 34817561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders.
    Zu S; Xiang YT; Liu J; Zhang L; Wang G; Ma X; Kilbourne AM; Ungvari GS; Chiu HF; Lai KY; Wong SY; Yu DS; Li ZJ
    J Affect Disord; 2014 Jan; 152-154():262-7. PubMed ID: 24140226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial.
    Dunn BD; Warbrick L; Hayes R; Montero-Marin J; Reed N; Dalgleish T; Kuyken W
    J Consult Clin Psychol; 2024 Sep; 92(9):619-629. PubMed ID: 39418459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.
    Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
    Trials; 2010 Oct; 11():99. PubMed ID: 20961444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression: A Randomized Clinical Trial.
    Aust S; Brakemeier EL; Spies J; Herrera-Melendez AL; Kaiser T; Fallgatter A; Plewnia C; Mayer SV; Dechantsreiter E; Burkhardt G; Strauß M; Mauche N; Normann C; Frase L; Deuschle M; Böhringer A; Padberg F; Bajbouj M
    JAMA Psychiatry; 2022 Jun; 79(6):528-537. PubMed ID: 35442431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
    Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants.
    Bockting CL; Elgersma HJ; van Rijsbergen GD; de Jonge P; Ormel J; Buskens E; Stant AD; de Jong PJ; Peeters FP; Huibers MJ; Arntz A; Muris P; Nolen WA; Schene AH; Hollon SD
    BMC Psychiatry; 2011 Jan; 11():8. PubMed ID: 21226937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.